3-甲基-2-苯基-1-吲哚的合成、抗增殖作用及拓扑异构酶II抑制活性
Synthesis, Antiproliferative Effect, and Topoisomerase II Inhibitory Activity of 3-Methyl-2-phenyl-1-indoles.
作者信息
Zidar Nace, Secci Daniela, Tomašič Tihomir, Mašič Lucija Peterlin, Kikelj Danijel, Passarella Daniele, Argaez Aida Nelly Garcia, Hyeraci Mariafrancesca, Dalla Via Lisa
机构信息
University of Ljubljana, Faculty of Pharmacy, Aškerčeva cesta 7, 1000 Ljubljana, Slovenia.
Department of Chemistry, University of Milan, Via Golgi 19, 20133 Milan, Italy.
出版信息
ACS Med Chem Lett. 2020 Jan 24;11(5):691-697. doi: 10.1021/acsmedchemlett.9b00557. eCollection 2020 May 14.
Abstract
A series of 3-methyl-2-phenyl-1-indoles was prepared and investigated for antiproliferative activity on three human tumor cell lines, HeLa, A2780, and MSTO-211H, and some structure-activity relationships were drawn up. The GI values of the most potent compounds ( and ) were lower than 5 μM in all tested cell lines. For the most biologically relevant derivatives, the effect on human DNA topoisomerase II relaxation activity was investigated, which highlighted the good correlation between the antiproliferative effect and topoisomerase II inhibition. The most potent derivative, , was shown to induce the apoptosis pathway. The obtained results highlight 3-methyl-2-phenyl-1-indole as a promising scaffold for further optimization of compounds with potent antiproliferative and antitopoisomerase II activities.
摘要
制备了一系列3-甲基-2-苯基-1-吲哚，并研究了它们对三种人类肿瘤细胞系HeLa、A2780和MSTO-211H的抗增殖活性，得出了一些构效关系。在所有测试细胞系中，最具活性的化合物（和）的GI值均低于5μM。对于最具生物学相关性的衍生物，研究了其对人DNA拓扑异构酶II松弛活性的影响，这突出了抗增殖作用与拓扑异构酶II抑制之间的良好相关性。最具活性的衍生物被证明可诱导凋亡途径。所得结果表明，3-甲基-2-苯基-1-吲哚是进一步优化具有强效抗增殖和抗拓扑异构酶II活性化合物的有前景的骨架。
相似文献
1
Synthesis, Antiproliferative Effect, and Topoisomerase II Inhibitory Activity of 3-Methyl-2-phenyl-1-indoles.3-甲基-2-苯基-1-吲哚的合成、抗增殖作用及拓扑异构酶II抑制活性
ACS Med Chem Lett. 2020 Jan 24;11(5):691-697. doi: 10.1021/acsmedchemlett.9b00557. eCollection 2020 May 14.
2
Synthesis of novel indole derivatives as promising DNA-binding agents and evaluation of antitumor and antitopoisomerase I activities.新型吲哚衍生物作为有前景的DNA结合剂的合成及其抗肿瘤和抗拓扑异构酶I活性的评估。
Eur J Med Chem. 2017 Aug 18;136:511-522. doi: 10.1016/j.ejmech.2017.05.012. Epub 2017 May 4.
3
Design, synthesis, in vitro antiproliferative activity and apoptosis-inducing studies of 1-(3',4',5'-trimethoxyphenyl)-3-(2'-alkoxycarbonylindolyl)-2-propen-1-one derivatives obtained by a molecular hybridisation approach.通过分子杂交方法获得的 1-(3',4',5'-三甲氧基苯基)-3-(2'-烷氧基羰基吲哚基)-2-丙烯-1-酮衍生物的设计、合成、体外增殖活性和诱导凋亡研究。
J Enzyme Inhib Med Chem. 2018 Dec;33(1):1225-1238. doi: 10.1080/14756366.2018.1493473.
4
Thiosemicarbazones and 4-thiazolidinones indole-based derivatives: Synthesis, evaluation of antiproliferative activity, cell death mechanisms and topoisomerase inhibition assay.硫代氨基脲和基于吲哚的4-噻唑烷酮衍生物：合成、抗增殖活性评估、细胞死亡机制及拓扑异构酶抑制试验
Eur J Med Chem. 2017 Aug 18;136:305-314. doi: 10.1016/j.ejmech.2017.05.023. Epub 2017 May 8.
5
Synthesis and preliminary evaluation of 3-thiocyanato-1H-indoles as potential anticancer agents.合成及初步评价 3-硫氰基-1H-吲哚作为潜在的抗癌剂。
Eur J Med Chem. 2016 Aug 8;118:21-6. doi: 10.1016/j.ejmech.2016.04.039. Epub 2016 Apr 19.
6
Cytotoxicity and DNA topoisomerase inhibitory activity of benz[f]indole-4,9-dione analogs.苯并[f]吲哚-4,9-二酮类似物的细胞毒性和DNA拓扑异构酶抑制活性
Biosci Biotechnol Biochem. 2003 Sep;67(9):1944-9. doi: 10.1271/bbb.67.1944.
7
Synthesis and biological evaluation of novel pyrazoline derivatives containing indole skeleton as anti-cancer agents targeting topoisomerase II.新型含吲哚骨架吡唑啉衍生物的合成及作为拓扑异构酶 II 靶点的抗癌活性评价。
Eur J Med Chem. 2020 Aug 15;200:112459. doi: 10.1016/j.ejmech.2020.112459. Epub 2020 May 21.
8
Design, synthesis and biological evaluation of benzimidazole-rhodanine conjugates as potent topoisomerase II inhibitors.作为高效拓扑异构酶II抑制剂的苯并咪唑-罗丹宁缀合物的设计、合成及生物学评价
Medchemcomm. 2018 Jun 2;9(7):1194-1205. doi: 10.1039/c8md00278a. eCollection 2018 Jul 1.
9
Facile one-pot synthesis, antiproliferative evaluation and structure-activity relationships of 3-amino-1H-indoles and 3-amino-1H-7-azaindoles.3-氨基-1H-吲哚和 3-氨基-1H-7-氮杂吲哚的简便一锅法合成、抗增殖评价及构效关系研究。
Bioorg Chem. 2019 Jul;88:102914. doi: 10.1016/j.bioorg.2019.04.008. Epub 2019 Apr 10.
10
Design, synthesis, topoisomerase I & II inhibitory activity, antiproliferative activity, and structure-activity relationship study of pyrazoline derivatives: An ATP-competitive human topoisomerase IIα catalytic inhibitor.吡唑啉衍生物的设计、合成、拓扑异构酶I和II抑制活性、抗增殖活性及构效关系研究：一种ATP竞争性人拓扑异构酶IIα催化抑制剂
Bioorg Med Chem. 2016 Apr 15;24(8):1898-908. doi: 10.1016/j.bmc.2016.03.017. Epub 2016 Mar 8.
引用本文的文献
1
From Sea to Science: Coral Aquaculture for Sustainable Anticancer Drug Development.从海洋到科学：珊瑚养殖用于可持续抗癌药物开发。
Mar Drugs. 2024 Jul 19;22(7):323. doi: 10.3390/md22070323.
2
New antiproliferative 3-substituted oxindoles inhibiting EGFR/VEGFR-2 and tubulin polymerization.新型抗增殖 3-取代氧吲哚类化合物，抑制 EGFR/VEGFR-2 和微管聚合。
Mol Divers. 2024 Apr;28(2):563-580. doi: 10.1007/s11030-023-10603-z. Epub 2023 Feb 15.
3
A Mini Review of Novel Topoisomerase II Inhibitors as Future Anticancer Agents.新型拓扑异构酶 II 抑制剂的综述：未来的抗癌药物。
Int J Mol Sci. 2023 Jan 28;24(3):2532. doi: 10.3390/ijms24032532.
4
Target-based anticancer indole derivatives and insight into structure‒activity relationship: A mechanistic review update (2018-2021).基于靶点的抗癌吲哚衍生物及其构效关系洞察：机制综述更新（2018 - 2021年）
Acta Pharm Sin B. 2022 Jul;12(7):3006-3027. doi: 10.1016/j.apsb.2022.03.021. Epub 2022 Apr 1.
5
New Multi-Targeted Antiproliferative Agents: Design and Synthesis of IC261-Based Oxindoles as Potential Tubulin, CK1 and EGFR Inhibitors.新型多靶点抗增殖剂：基于IC261的吲哚酮类化合物作为潜在微管蛋白、细胞周期蛋白依赖性激酶1和表皮生长因子受体抑制剂的设计与合成
Pharmaceuticals (Basel). 2021 Oct 30;14(11):1114. doi: 10.3390/ph14111114.
6
Biological Properties of New Chiral 2-Methyl-5,6,7,8-tetrahydroquinolin-8-amine-based Compounds.新型手性 2-甲基-5,6,7,8-四氢喹啉-8-胺类化合物的生物学性质。
Molecules. 2020 Nov 27;25(23):5561. doi: 10.3390/molecules25235561.
本文引用的文献
1
A comprehensive review of topoisomerase inhibitors as anticancer agents in the past decade.近十年拓扑异构酶抑制剂作为抗癌药物的全面综述。
Eur J Med Chem. 2019 Jun 1;171:129-168. doi: 10.1016/j.ejmech.2019.03.034. Epub 2019 Mar 20.
2
Recent developments in topoisomerase-targeted cancer chemotherapy.拓扑异构酶靶向癌症化疗的最新进展
Acta Pharm Sin B. 2018 Oct;8(6):844-861. doi: 10.1016/j.apsb.2018.07.008. Epub 2018 Jul 25.
3
Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.全球癌症统计数据 2018：GLOBOCAN 对全球 185 个国家/地区 36 种癌症的发病率和死亡率的估计。
CA Cancer J Clin. 2018 Nov;68(6):394-424. doi: 10.3322/caac.21492. Epub 2018 Sep 12.
4
Topoisomerases as anticancer targets.拓扑异构酶作为抗癌靶点。
Biochem J. 2018 Jan 23;475(2):373-398. doi: 10.1042/BCJ20160583.
5
Drugging the 'undruggable' cancer targets.针对“不可成药”的癌症靶点研发药物。
Nat Rev Cancer. 2017 Aug;17(8):502-508. doi: 10.1038/nrc.2017.36. Epub 2017 Jun 23.
6
Mechanisms and regulation of DNA replication initiation in eukaryotes.真核生物中DNA复制起始的机制与调控
Crit Rev Biochem Mol Biol. 2017 Apr;52(2):107-144. doi: 10.1080/10409238.2016.1274717. Epub 2017 Jan 17.
7
Roles of eukaryotic topoisomerases in transcription, replication and genomic stability.真核生物拓扑异构酶在转录、复制和基因组稳定性中的作用。
Nat Rev Mol Cell Biol. 2016 Nov;17(11):703-721. doi: 10.1038/nrm.2016.111. Epub 2016 Sep 21.
8
Discovery of mono- and disubstituted 1H-pyrazolo[3,4]pyrimidines and 9H-purines as catalytic inhibitors of human DNA topoisomerase IIα.单取代和双取代的1H-吡唑并[3,4]嘧啶及9H-嘌呤作为人DNA拓扑异构酶IIα催化抑制剂的发现。
ChemMedChem. 2015 Feb;10(2):345-59. doi: 10.1002/cmdc.201402459. Epub 2014 Dec 17.
9
Monocyclic 4-amino-6-(phenylamino)-1,3,5-triazines as inhibitors of human DNA topoisomerase IIα.单环4-氨基-6-（苯氨基）-1,3,5-三嗪作为人DNA拓扑异构酶IIα的抑制剂
Bioorg Med Chem Lett. 2014 Dec 15;24(24):5762-5768. doi: 10.1016/j.bmcl.2014.10.042. Epub 2014 Oct 22.
10
Synthesis, antiproliferative and mitochondrial impairment activities of bis-alkyl-amino transplatinum complexes.双烷基氨基transplatinum 配合物的合成、抗增殖和线粒体损伤活性。
Bioorg Med Chem. 2013 Nov 15;21(22):6965-72. doi: 10.1016/j.bmc.2013.09.025. Epub 2013 Sep 19.
Zotero 插件